What is KPV?
KPV is a tripeptide — just three amino acids, lysine-proline-valine. It’s the C-terminal active fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), a hormone the body uses, among other things, to regulate inflammation.1
Researchers became interested in KPV because it appears to carry much of alpha-MSH’s anti-inflammatory activity in a far smaller, more stable molecule. As with most peptides in this space, the honest caveat comes first: the bulk of the evidence is preclinical, and large human trials are still lacking.2
Benefits & what it’s studied for
In models of colitis and inflammatory bowel disease, KPV appeared to reduce intestinal inflammation, which is why it’s often discussed for gut goals.2 Human evidence remains early.
KPV has been studied topically for inflammatory skin conditions and wound healing, drawing on alpha-MSH’s known skin activity.3 Translation to routine human use is unproven.
Like its parent hormone, KPV has shown antimicrobial effects in lab studies — an area of interest but still preclinical.3
How does KPV work?
The leading idea is that KPV travels into cells and dampens key inflammatory signaling — including the NF-κB pathway that drives much of the body’s inflammatory response.1 By turning down those signals inside the cell, it appears to reduce the production of inflammatory messengers rather than blocking a single target on the surface.
Dosing & administration
KPV is used in oral, topical, and injectable forms depending on the goal — oral and topical for gut and skin, injectable for systemic use. The honest caveat: long-term human safety has not been established.
This is educational, not medical advice. We don’t publish dosing. The right form, dose, and duration are decided by a licensed provider after evaluation. Not evaluated by the FDA.
Legality & status
KPV is not FDA-approved as a drug and is not sold over the counter as a therapeutic. It isn’t a controlled substance, but legitimate access is through a licensed provider and compounding pharmacy where permitted. For the bigger picture, see how legitimate peptide therapy works.
Thinking about KPV?
Talk to a licensed provider who can tell you if it fits your goals — and build a safe protocol.
Research & references
- 1Brzoska T, et al. Alpha-MSH and its C-terminal tripeptide KPV: anti-inflammatory actions. Endocr Rev. link pending
- 2Dalmasso G, et al. KPV reduces intestinal inflammation in colitis models. Gastroenterology. link pending
- 3Review of KPV in skin inflammation, wound healing, and antimicrobial activity. Citation to be finalized. link pending
Reference links are illustrative placeholders — replace with verified PubMed/journal URLs before publishing.
Frequently asked questions
What is KPV used for?+
KPV is studied mainly as an anti-inflammatory peptide — for gut and intestinal inflammation, skin inflammation, and wound healing. Most of the evidence is preclinical; rigorous human trials are limited.
Is KPV the same as BPC-157?+
No. KPV is an anti-inflammatory tripeptide derived from alpha-MSH, while BPC-157 is a tissue-repair peptide derived from a gastric protein. They’re sometimes paired for gut goals but they work differently.
Can you take KPV orally?+
Oral and topical forms are commonly used, especially for gut or skin goals, alongside injectable forms. The right route is a clinical decision made by a licensed provider.
Is KPV safe?+
long-term human safety has not been established. It should only be used under medical supervision.
Is KPV FDA-approved?+
No. KPV is not FDA-approved. Access is through a licensed provider and compounding pharmacy where legally permitted — it is not an over-the-counter therapeutic.